Patents by Inventor Scott Kachlany

Scott Kachlany has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11540460
    Abstract: An apparatus for applying a liquid to a plant growing in soil includes a handheld assembly having a spray configuration for applying a liquid to a plant as a spray at a location above the surface of the soil in which the plant is growing, and a probe configuration for applying a liquid below the surface of the soil proximate to the roots of the plant. The assembly is selectively reconfigurable by a user between the first spray configuration and the second probe configuration.
    Type: Grant
    Filed: July 29, 2019
    Date of Patent: January 3, 2023
    Assignee: Gardinnovations
    Inventors: Scott Kachlany, Teri Chu
  • Patent number: 10993989
    Abstract: This invention concerns compositions and methods of treating or diagnosing inflammatory disorders and other disorders, as well as compositions and methods of treating HIV.
    Type: Grant
    Filed: March 6, 2020
    Date of Patent: May 4, 2021
    Assignees: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY, ACTINOBAC BIOMED, INC.
    Inventors: Scott Kachlany, Benjamin A. Belinka, Jr.
  • Publication number: 20200306339
    Abstract: This invention concerns compositions and methods of treating or diagnosing inflammatory disorders and other disorders, as well as compositions and methods of treating HIV.
    Type: Application
    Filed: March 6, 2020
    Publication date: October 1, 2020
    Inventors: Scott Kachlany, Benjamin A. Belinka, JR.
  • Publication number: 20200037523
    Abstract: An apparatus for applying a liquid to a plant growing in soil includes a handheld assembly having a spray configuration for applying a liquid to a plant as a spray at a location above the surface of the soil in which the plant is growing, and a probe configuration for applying a liquid below the surface of the soil proximate to the roots of the plant. The assembly is selectively reconfigurable by a user between the first spray configuration and the second probe configuration.
    Type: Application
    Filed: July 29, 2019
    Publication date: February 6, 2020
    Inventors: Scott Kachlany, Teri Chu
  • Patent number: 10149889
    Abstract: The invention relates to pharmaceutical compositions comprising leukotoxin, including methods to treat lymphoma, and methods to diagnose lymphoma. The lymphoma includes lymphoma cells expressing activated LFA-1, and the leukotoxin binds to the activated LFA-1 on the lymphoma cells and destroys the lymphoma cells by apoptosis or necrosis, thereby treating said lymphoma.
    Type: Grant
    Filed: March 28, 2016
    Date of Patent: December 11, 2018
    Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventor: Scott Kachlany
  • Patent number: 9950030
    Abstract: This invention concerns compositions and methods of treating or diagnosing ocular disease.
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: April 24, 2018
    Assignees: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY, ACTINOBAC BIOMED, INC.
    Inventors: Scott Kachlany, Benjamin Belinka
  • Publication number: 20180071360
    Abstract: The invention relates to pharmaceutical compositions comprising leukotoxin, including methods to treat lymphoma, and methods to diagnose lymphoma. The lymphoma includes lymphoma cells expressing activated LFA-1, and the leukotoxin binds to the activated LFA-1 on the lymphoma cells and destroys the lymphoma cells by apoptosis or necrosis, thereby treating said lymphoma.
    Type: Application
    Filed: March 28, 2016
    Publication date: March 15, 2018
    Inventor: Scott Kachlany
  • Patent number: 9849156
    Abstract: This invention concerns compositions and methods of treating or diagnosing inflammatory disorders and other disorders, as well as compositions and methods of treating HIV.
    Type: Grant
    Filed: March 24, 2016
    Date of Patent: December 26, 2017
    Assignees: RUTGERS, THE STATE UNIVERSIT OF NEW JERSEY, ACTINOBAC BIOMED, INC.
    Inventors: Scott Kachlany, Benjamin Belinka
  • Patent number: 9724384
    Abstract: The present invention provides pharmaceutical compositions comprising leukotoxin for the treatment of lung inflammation.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: August 8, 2017
    Assignees: Rutgers, the State University of New Jersey, Actinobac Biomed, Inc.
    Inventors: Scott Kachlany, Benjamin Belinka
  • Publication number: 20160339077
    Abstract: This invention concerns compositions and methods of treating or diagnosing inflammatory disorders and other disorders, as well as compositions and methods of treating HIV.
    Type: Application
    Filed: March 24, 2016
    Publication date: November 24, 2016
    Inventors: Scott Kachlany, Benjamin Belinka
  • Publication number: 20160287662
    Abstract: This invention concerns compositions and methods of treating or diagnosing ocular disease.
    Type: Application
    Filed: June 27, 2014
    Publication date: October 6, 2016
    Inventors: Scott Kachlany, Benjamin Belinka
  • Publication number: 20160243191
    Abstract: The invention relates to pharmaceutical compositions comprising leukotoxin, including methods to treat lymphoma, and methods to diagnose lymphoma. The lymphoma includes lymphoma cells expressing activated LFA-1, and the leukotoxin binds to the activated LFA-1 on the lymphoma cells and destroys the lymphoma cells by apoptosis or necrosis, thereby treating said lymphoma.
    Type: Application
    Filed: March 28, 2016
    Publication date: August 25, 2016
    Inventor: Scott Kachlany
  • Patent number: 9352017
    Abstract: The invention relates to pharmaceutical compositions comprising leukotoxin, a chemotherapeutic agent and a pharmaceutically acceptable carrier, including methods to treat cancer, and methods to induce apoptosis.
    Type: Grant
    Filed: March 16, 2012
    Date of Patent: May 31, 2016
    Assignees: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY, ACTINOBAC BIOMED, INC.
    Inventors: Scott Kachlany, Benjamin Belinka
  • Patent number: 9295710
    Abstract: This invention concerns compositions and methods of treating or diagnosing inflammatory disorders and other disorders, as well as compositions and methods of treating HIV.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: March 29, 2016
    Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventor: Scott Kachlany
  • Publication number: 20150366937
    Abstract: The present invention provides pharmaceutical compositions comprising leukotoxin for the treatment of lung inflammation.
    Type: Application
    Filed: June 19, 2015
    Publication date: December 24, 2015
    Applicants: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventors: Scott Kachlany, Benjamin Belinka
  • Publication number: 20150202255
    Abstract: This invention concerns compositions and methods of treating or diagnosing inflammatory disorders and other disorders, as well as compositions and methods of treating HIV.
    Type: Application
    Filed: December 15, 2014
    Publication date: July 23, 2015
    Inventor: Scott Kachlany
  • Publication number: 20080318252
    Abstract: This invention relates to an assay that allows for the rapid determination of the activity of a given drug against leukemic cells either taken from a patient or derived from a cell line. The assay is performed in the presence of whole blood or serum.
    Type: Application
    Filed: April 23, 2008
    Publication date: December 25, 2008
    Inventor: Scott Kachlany